NCT00868296View on ClinicalTrials.gov

Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Gastroesophageal Reflux
Interventions
DRUG

pantoprazole

Trial Locations (71)

2650

Edegem

3000

Leuven

3235

Pietermaritzburg

3630

Durban

4067

Overport

7500

Panorama

8032

Zurich

10032

New York

10467

The Bronx

11219

Brooklyn

12208

Albany

14467

Potsdam

20010

Washington D.C.

21201

Baltimore

23298

Richmond

25123

Brescia

26506

Morgantown

27157

Winston-Salem

27710

Durham

30322

Atlanta

33101

Miami

33323

Sunrise

38163

Memphis

40202

Louisville

44797

Bochum

48503

Flint

49074

Osnabrück

53226

Milwaukee

60068

Park Ridge

60614

Chicago

68105

Omaha

70121

New Orleans

73104

Oklahoma City

75674

Paris

75935

Paris

78229

San Antonio

80121

Napoli

83704

Boise

84113

Salt Lake City

85006

Phoenix

92103

San Diego

92354

Loma Linda

92868

Orange

95817

Sacramento

96826

Honolulu

94609-1809

Oakland

06520-8064

New Haven

32610-0296

Gainesville

40536-0284

Lexington

02114

Boston

08103

Camden

08901

New Brunswick

07103

Newark

10595-1689

Valhalla

97239-3042

Portland

17822-1320

Danville

37232-9550

Nashville

75390-9063

Dallas

05401

Burlington

Unknown

Brisbane

V6H 3V4

Vancouver

K1Y 4E9

Ottawa

M5G 1X8

Toronto

H3H 1P3

Montreal

G1V 4G2

Sainte-Foy

00161

Roma

3015 GJ

Rotterdam

85-165

Bydgoszcz

33-663

Krakow

20-093

Lublin

0083

Pretoria

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00868296 - Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD) | Biotech Hunter | Biotech Hunter